Julphar Bangladesh Ltd. Julphar Bangladesh Ltd.

Julphar Bangladesh has Launched antiviral drug- Entecavir (Enbee 0.5mg Tablet)

After successful introduction of Hepatitis C product in our virology portfolio from 2015, we are the consistent leader in this Hepatitis C market. Now, Julphar Bangladesh has launched antiviral drug Enbee 0.5 (Entecavir 0.5 mg) tablet for the treatment of Hepatitis B viral infection.


    Stay ahead of CHB

  • AASLD, APASL & WHO recommended Enbee as first line therapy for HBV infections
  • Ensures significant efficacy
  • Ensures superior efficacy over Peg-IFN
  • Ensures excellent tolerability
  • Remarkably suppresses HBV DNA
  • Distinctly normalizes ALT



Last Update: 23 Jan 2018

© Julphar Bangladesh Ltd. 2008 - 2018. All Rig hts Reserved.
Developed By : Alien BD Inforamtion & Technology